
Immunophenotypic Aberrancies in Acute Lymphoblastic Leukaemia: A Cross-sectional Study from a Tertiary Care Centre in Rajasthan, India EC01-EC05
[ABSTRACT ] | [FULL TEXT ] | [ PDF ] | [Google Scholar]
EGFR Expression and its Association with Molecular Subtypes of Breast Carcinoma: A Cross-sectional Study EC06-EC10
[ABSTRACT ] | [FULL TEXT ] | [ PDF ] | [Google Scholar]
Vulval Verrucous Carcinoma: A Case Report of Rare Subtype ED01-ED03
[ABSTRACT ] | [FULL TEXT ] | [ PDF ] | [Google Scholar]
Gliosarcoma: A Very Rare Biphasic Histopathological Engima Associated with Very Poor Prognostic Parameters ED04-ED07
[ABSTRACT ] | [FULL TEXT ] | [ PDF ] | [Google Scholar]
Utility of CA15-3 as a Tumour Proliferation Marker in Breast Carcinoma Patients: A Cross-sectional Study Protocol EK01-EK04
[ABSTRACT ] | [FULL TEXT ] | [ PDF ] | [Google Scholar]
Blood Transfusion Recipients with Alloantibodies of Anti C, c, E, e and Anti D+C (?G): A Series of 11 Cases ER01-ER03
[ABSTRACT ] | [FULL TEXT ] | [ PDF ] | [Google Scholar]
All the research studies published were performed in accordance to the Declaration of Helsinki. Written consent was obtained from all the included subjects (or the responsible next kin), where ever applicable. In case reports or any article which includes patients images, permission was sought from the patient (or the responsible next kin) for publication. Whether or not this has been explicitly stated in the manuscript, this was declared by the authors at the time of submission of manuscript to the journal. In a rare event, if the consent could not be obtained due to loss of patient for follow up or death or loss of contact, even after reasonable effort, the editors then decided on case by case basis, weighing on the individual contribution the report will make to advancement of medical literature.